Results 111 to 120 of about 224,706 (187)

The endonasale orbital decompression in the management of Graves´ orbitopathy

, 2011
Die endonasal mirkoskopisch-endoskopische Orbitadekompression stellt eine sichere und effiziente Therapieform in der Behandlung der endokrinen Orbitopathie dar.Orbitadecompression is a safe method in the management of Graves ...
Rauch, Sabine
core   +2 more sources

Graves' orbitopathy

Medicinska istrazivanja
Graves' orbitopathy (GO) represents eye changes that most often occur in patients with autoimmune hyperthyroidism-Graves' disease (GD), although they can also occur much less frequently in euthyroid and hypothyroid patients. About 30% of patients with Graves' disease have GO, while less than 10% develop a more severe form that requires treatment.
openaire   +1 more source

Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy

, 2017
Objective The purpose of this study was to determine the performance of the apparent diffusion coefficient in the detection of involvement of the medial and lateral rectus muscles in patients with Graves' orbitopathy.
Mohamed E Moawad, Nader El-Metwaly, Amr A El-Said, Mohamed El-Hadidy, Ahmed AK Abdel Razek   +4 more
core   +1 more source

GRAVES' ORBITOPATHY: AN UPDATED REVIEW OF PATHOGENESIS, CLINICAL FEATURES, AND TREATMENT STRATEGIES [PDF]

Graves’ orbitopathy (GO) otherwise known as thyroid ophthalmopathy or thyroid eye disease (TED) is an ocular disorder that involves autoimmune inflammation of the soft tissues of the orbit.
Konrad Kotte, Olaf Jadanowski, Bartosz Komsta, Przemysław Piskorz, Kamil Łebek, Daria Litworska-Sójka, Wojciech Pabis, Julia Lipiec, Alicja Bury, Weronika Sobota   +9 more
core   +1 more source

De-identified raw data for relationship between sociodemographic factors and Graves' orbitopathy

, 2018
Deidentified Raw Data for the research project "Relationship Between Sociodemographic Factors and Graves' Orbitopathy" separated into diagnosis based on ICD 9 codes.
Shortell, J (via Mendeley Data)
core   +1 more source

[Graves' Orbitopathy].

Klinische Monatsblatter fur Augenheilkunde, 2017
A, Eckstein, J, Esser, S, Mattheis, U, Berchner-Pfannschmidt   +3 more
  +7 more sources

Mouse Model of Graves' Orbitopathy in Current Research and Future Perspectives. [PDF]

Medicina (Kaunas)
Lee GM, Jung WH, Kim Y, Oh MI, Jang SY.
europepmc   +1 more source

Sirolimus for the treatment of Graves' orbitopathy. [PDF]

Thyroid Res
Comi S, Sabini E, Cosentino G, Santini F, Marinò M.   +4 more
europepmc   +1 more source

Dipeptidyl peptidase-4 inhibitors suppress myofibroblastic differentiation and hyaluronan synthesis in Graves' orbitopathy fibroblasts. [PDF]

Front Endocrinol (Lausanne)
Shih CW, Tsai FC, Shih SR, Liao SL, Chu I, Hong TM, Liao NL, Wei YH.   +7 more
europepmc   +1 more source

Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves' orbitopathy

, 2010
A multidisciplinary approach to the management of Graves' orbitopathy is widely recommended. The optimal model for health care delivery to patients with Graves' orbitopathy is combined thyroid-eye clinics.
Wiersinga, Wilmar M.
core